Sotac Pharmaceuticals Limited (NSE:SOTAC)

India flag India · Delayed Price · Currency is INR
105.00
+5.00 (5.00%)
Jan 23, 2026, 1:00 PM IST
-7.33%
Market Cap1.16B
Revenue (ttm)846.72M
Net Income (ttm)85.60M
Shares Out11.05M
EPS (ttm)7.74
PE Ratio13.57
Forward PEn/a
Dividend0.10 (0.10%)
Ex-Dividend DateSep 19, 2025
Volume1,200
Average Volume3,180
Open105.00
Previous Close100.00
Day's Range105.00 - 105.00
52-Week Range88.05 - 152.35
Beta-0.12
RSI30.42
Earnings DateFeb 4, 2026

About Sotac Pharmaceuticals

Sotac Pharmaceuticals Limited engages in the production, manufacturing, processing, and sale of various pharmaceutical products in India. Its therapeutic product portfolio includes anti-diabetic, anti-psychotic, vitamins, minerals, iron supplements, anti-cold, anti-allergic, dermatological solutions, antacid, anti-ulcerants, PPI, anti-emetics, cardiac, anti-hypertensives, analgesic, anti-pyretic, anti-inflammatory, anti-bacterial, anti-viral, general antibiotics, IP-lactams and non-IP-lactams, anti-fungal, and cephalosporin products. The compan... [Read more]

Industry Pharmaceutical Preparations
Founded 2014
Employees 127
Stock Exchange National Stock Exchange of India
Ticker Symbol SOTAC
Full Company Profile

Financial Performance

In 2024, Sotac Pharmaceuticals's revenue was 1.00 billion, a decrease of -3.57% compared to the previous year's 1.04 billion. Earnings were 80.27 million, an increase of 87.48%.

Financial Statements